{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:59Z","timestamp":1786982519533,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03957-3","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:13:58Z","timestamp":1763734438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of nomograms for distant metastasis and prognosis of small intestinal neuroendocrine tumors"],"prefix":"10.1007","volume":"16","author":[{"given":"Changyan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"11","key":"3957_CR1","doi-asserted-by":"publisher","first-page":"e13205","DOI":"10.1111\/jne.13205","volume":"34","author":"K Daskalakis","year":"2022","unstructured":"Daskalakis K, Wedin M, Tsoli M, Kogut A, Srirajaskanthan R, Sarras K, et al. Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence-free survival. J Neuroendocrinol. 2022;34(11):e13205.","journal-title":"J Neuroendocrinol"},{"issue":"10","key":"3957_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the Incidence, Prevalence, and survival outcomes in patients with neuroendocrine tumors in the united States. JAMA Oncol. 2017;3(10):1335.","journal-title":"JAMA Oncol"},{"issue":"12","key":"3957_CR3","doi-asserted-by":"publisher","first-page":"7822","DOI":"10.1245\/s10434-022-12030-0","volume":"29","author":"S Levy","year":"2022","unstructured":"Levy S, Arthur JD, Banks M, Kok NFM, Fenwick SW, Diaz-Nieto R, et al. Primary tumor resection is associated with improved Disease-Specific mortality in patients with stage IV small intestinal neuroendocrine tumors (NETs): A comparison of upfront surgical resection versus a watch and wait strategy in two specialist NET centers. Ann Surg Oncol. 2022;29(12):7822\u201332.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3957_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/cancers13030443","volume":"13","author":"A Bla\u017eevi\u0107","year":"2021","unstructured":"Bla\u017eevi\u0107 A, Brabander T, Zandee WT, Hofland J, Franssen GJH, Van Velthuysen MLF, et al. Evolution of the mesenteric mass in small intestinal neuroendocrine tumours. Cancers. 2021;13(3):443.","journal-title":"Cancers"},{"issue":"2","key":"3957_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000335629","volume":"95","author":"UF Pape","year":"2012","unstructured":"Pape UF, Perren A, Niederle B, Gross D, Gress T, Costa F, et al. ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the Jejuno-Ileum and the appendix including goblet cell carcinomas. Neuroendocrinology. 2012;95(2):135\u201356.","journal-title":"Neuroendocrinology"},{"key":"3957_CR6","doi-asserted-by":"crossref","unstructured":"Pavel M, \u00d6berg K, Falconi M, Krenning EP, Sundin A, Perren A, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(7):844\u201360.","DOI":"10.1016\/j.annonc.2020.03.304"},{"key":"3957_CR7","doi-asserted-by":"crossref","unstructured":"Norl\u00e9n O, Montan H, Hellman P, St\u00e5lberg P, Sundin A. Preoperative68 Ga\u2010DOTA\u2010Somatostatin Analog\u2010PET\/CT Hybrid Imaging Increases Detection Rate of Intra\u2010abdominal Small Intestinal Neuroendocrine Tumor Lesions. World j surg. 2018;42(2):498\u2013505.","DOI":"10.1007\/s00268-017-4364-1"},{"issue":"11","key":"3957_CR8","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00535-021-01827-7","volume":"56","author":"T Ito","year":"2021","unstructured":"Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, et al. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. J Gastroenterol. 2021;56(11):1033\u201344.","journal-title":"J Gastroenterol"},{"key":"3957_CR9","doi-asserted-by":"crossref","unstructured":"Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9(1):61\u201372.","DOI":"10.1016\/S1470-2045(07)70410-2"},{"issue":"4","key":"3957_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1159\/000197899","volume":"89","author":"J Strosberg","year":"2009","unstructured":"Strosberg J, Gardner N, Kvols L. Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the Mid-Gut. Neuroendocrinology. 2009;89(4):471\u20136.","journal-title":"Neuroendocrinology"},{"issue":"11","key":"3957_CR11","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/bjs.8842","volume":"99","author":"G Capurso","year":"2012","unstructured":"Capurso G, Rinzivillo M, Bettini R, Boninsegna L, Fave GD, Falconi M. Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. Br J Surg. 2012;99(11):1480\u20136.","journal-title":"Br J Surg"},{"issue":"4","key":"3957_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/cncr.29099","volume":"121","author":"J Hallet","year":"2015","unstructured":"Hallet J, Law CHL, Cukier M, Saskin R, Liu N, Singh S. Exploring the rising incidence of neuroendocrine tumors: A population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015;121(4):589\u201397.","journal-title":"Cancer"},{"key":"3957_CR13","doi-asserted-by":"crossref","unstructured":"Chauhan A, Chan K, Halfdanarson TR, Bellizzi AM, Rindi G, O\u2019Toole D, et al. Critical updates in neuroendocrine tumors: version 9 American joint committee on cancer staging system for gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin. 2024;74(4):359\u201367.","DOI":"10.3322\/caac.21840"},{"issue":"1","key":"3957_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022;33(1):115\u201354.","journal-title":"Endocr Pathol"},{"key":"3957_CR15","doi-asserted-by":"crossref","unstructured":"Zhong Q, Chen Q, Xie J, Wang J, Lin J, Lu J, et al. Incidence trend and conditional survival estimates of gastroenteropancreatic neuroendocrine tumors: a large population-based study. Cancer Med. 2018;7(7):3521\u201333.","DOI":"10.1002\/cam4.1598"},{"key":"3957_CR16","doi-asserted-by":"crossref","unstructured":"Chen B, Zeng Y, Liu B, Lu G, Xiang Z, Chen J et al. Risk Factors, prognostic Factors, and nomograms for distant metastasis in patients with newly diagnosed osteosarcoma: a population-based study. Front Endocrinol. 2021;12:672024.","DOI":"10.3389\/fendo.2021.672024"},{"issue":"3","key":"3957_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/annonc\/mdz001","volume":"30","author":"D Dong","year":"2019","unstructured":"Dong D, Tang L, Li ZY, Fang MJ, Gao JB, Shan XH, et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol. 2019;30(3):431\u20138.","journal-title":"Ann Oncol"},{"key":"3957_CR18","doi-asserted-by":"publisher","first-page":"107327482513216","DOI":"10.1177\/10732748251321661","volume":"32","author":"C Fan","year":"2025","unstructured":"Fan C, Jiang A, Zhao R, Chen M. A novel Age-Based nomogram as the best predictor for Long-Term overall survival in head and neck Mucosa-Associated lymphoid tissue lymphoma. Cancer Control. 2025;32:10732748251321661.","journal-title":"Cancer Control"},{"issue":"8","key":"3957_CR19","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. JCO. 2008;26(8):1364\u201370.","journal-title":"JCO"},{"issue":"2","key":"3957_CR20","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1097\/JS9.0000000000002222","volume":"111","author":"J Wu","year":"2025","unstructured":"Wu J, Shang BQ, Shou JZ, Wang ZP. A nomogram for predicting lymph node metastases in nonmetastatic muscle-invasive bladder cancer: a SEER-based investigation. Int J Surg. 2025;111(2):2309\u201312.","journal-title":"Int J Surg"},{"key":"3957_CR21","doi-asserted-by":"crossref","unstructured":"Chen DW, Carr G, Worden FP, Veenstra CM, Haymart MR, Banerjee M. Survival prognostication in patients with differentiated thyroid cancer and distant metastases: a SEER population-based study. Thyroid\u00ae. 2024;34(7):837\u201345.","DOI":"10.1089\/thy.2023.0709"},{"key":"3957_CR22","doi-asserted-by":"crossref","unstructured":"Chokkakula S, Chong S, Yang YY, Huang L, Qian Y, Sun Q, et al. Assessing the prognosis mortality in patients with cutaneous verrucous carcinoma using Lasso-cox regression model: a retrospective study. Discov Oncol. 2025;13(1):1091.","DOI":"10.1007\/s12672-025-02893-6"},{"key":"3957_CR23","doi-asserted-by":"crossref","unstructured":"Boehm K, Larcher A, Beyer B, Tian Z, Tilki D, Steuber T, et al. Identifying the most informative prediction tool for Cancer-specific mortality after radical prostatectomy: comparative analysis of three commonly used preoperative prediction models. Eur Urol. 2016;69(6):1038\u201343.","DOI":"10.1016\/j.eururo.2015.07.051"},{"key":"3957_CR24","doi-asserted-by":"crossref","unstructured":"Lee SM, Liyanage SH, Wulaningsih W, Wolfe K, Carr T, Younis C et al. Toward an MRI-based nomogram for the prediction of transperineal prostate biopsy outcome: a physician and patient decision tool. Urol Oncol Semin Orig Investig. 2017;35(11):664.e11-664.e18.","DOI":"10.1016\/j.urolonc.2017.07.018"},{"key":"3957_CR25","doi-asserted-by":"crossref","unstructured":"Peng Y, Xu B, Zhang F, Wu R, Tong S, Mao Z. Incidence, survival, and prognostic nomogram of patients with small intestinal neuroendocrine tumors: a SEER population-based study. Medicine. 2024;103(37):e39616.","DOI":"10.1097\/MD.0000000000039616"},{"key":"3957_CR26","doi-asserted-by":"crossref","unstructured":"Panzuto F, Ramage J, Pritchard DM, Van Velthuysen MF, Schrader J, Begum N et al. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1\u2013G3. J Neuroendocrinology. 2023;35(8):e13306.","DOI":"10.1111\/jne.13306"},{"issue":"18","key":"3957_CR27","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1002\/sim.6152","volume":"33","author":"TA Gerds","year":"2014","unstructured":"Gerds TA, Andersen PK, Kattan MW. Calibration plots for risk prediction models in the presence of competing risks. Stat Med. 2014;33(18):3191\u2013203.","journal-title":"Stat Med"},{"issue":"2","key":"3957_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/070674370705200210","volume":"52","author":"DL Streiner","year":"2007","unstructured":"Streiner DL, Cairney J. What\u2019s under the ROC? An introduction to receiver operating characteristics curves. Can J Psychiatry. 2007;52(2):121\u20138.","journal-title":"Can J Psychiatry"},{"key":"3957_CR29","doi-asserted-by":"crossref","unstructured":"Kerr KF, Brown MD, Zhu K, Janes H. Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. JCO. 2016;20(21):2534\u201340.","DOI":"10.1200\/JCO.2015.65.5654"},{"key":"3957_CR30","doi-asserted-by":"publisher","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","volume":"96","author":"G Mathew","year":"2021","unstructured":"Mathew G, Agha R, Albrecht J, Goel P, Mukherjee I, Pai P, et al. STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg. 2021;96:106165.","journal-title":"Int J Surg"},{"key":"3957_CR31","doi-asserted-by":"publisher","first-page":"1019638","DOI":"10.3389\/fimmu.2022.1019638","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang Q, Qiao W, Zhang H, Liu B, Li J, Zang C, et al. Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma. Front Immunol. 2022;13:1019638.","journal-title":"Front Immunol"},{"key":"3957_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jclinepi.2022.08.016","volume":"151","author":"MW Heymans","year":"2022","unstructured":"Heymans MW, Twisk JWR. Handling missing data in clinical research. J Clin Epidemiol. 2022;151:185\u20138.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"3957_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.dld.2020.08.031","volume":"53","author":"V Andreasi","year":"2021","unstructured":"Andreasi V, Partelli S, Muffatti F, Manzoni MF, Capurso G, Falconi M. Update on gastroenteropancreatic neuroendocrine tumors. Dig Liver Disease. 2021;53(2):171\u201382.","journal-title":"Dig Liver Disease"},{"issue":"8","key":"3957_CR34","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1634\/theoncologist.2018-0604","volume":"24","author":"KEH Thomas","year":"2019","unstructured":"Thomas KEH, Voros BA, Boudreaux JP, Thiagarajan R, Woltering EA, Ramirez RA. Current treatment options in gastroenteropancreatic neuroendocrine carcinoma. Oncologist. 2019;24(8):1076\u201388.","journal-title":"Oncologist"},{"key":"3957_CR35","doi-asserted-by":"crossref","unstructured":"Diamantopoulos LN, Kalligeros M, Halfdanarson TR, Diamantis N, Toumpanakis C. Combination systemic therapies in advanced well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs): a comprehensive review of clinical trials and prospective studies. Biology. 2023;12(8):1069.","DOI":"10.3390\/biology12081069"},{"key":"3957_CR36","doi-asserted-by":"crossref","unstructured":"La Salvia A, Modica R, Rossi RE, Spada F, Rinzivillo M, Panzuto F, et al. Targeting neuroendocrine tumors with octreotide and lanreotide: key points for clinical practice from NET specialists. Cancer Treat Rev. 2023;117:102560.","DOI":"10.1016\/j.ctrv.2023.102560"},{"issue":"1","key":"3957_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41568-022-00529-3","volume":"23","author":"A Wahida","year":"2023","unstructured":"Wahida A, Buschhorn L, Fr\u00f6hling S, Jost PJ, Schneeweiss A, Lichter P, et al. The coming decade in precision oncology: six riddles. Nat Rev Cancer. 2023;23(1):43\u201354.","journal-title":"Nat Rev Cancer"},{"key":"3957_CR38","doi-asserted-by":"crossref","unstructured":"Li X, Fan Y, Tong J, Lou M. Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study. Front Endocrinol. 2024;15:1264952.","DOI":"10.3389\/fendo.2024.1264952"},{"issue":"S3","key":"3957_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1245\/s10434-010-1497-y","volume":"18","author":"P Taflampas","year":"2011","unstructured":"Taflampas P, Christodoulakis M, DeBree E. Prognostic impact of inferior mesenteric artery lymph node metastasis in colorectal cancer. Ann Surg Oncol. 2011;18(S3):235\u2013235.","journal-title":"Ann Surg Oncol"},{"key":"3957_CR40","doi-asserted-by":"crossref","unstructured":"Lee YTNM. Leiomyosarcoma of the gastro-intestinal tract: general pattern of metastasis and recurrence. Cancer Treat Rev. 1983;10(2):91\u2013101.","DOI":"10.1016\/0305-7372(83)90007-5"},{"issue":"1","key":"3957_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TGF\u03b2 biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2021;18(1):9\u201334.","journal-title":"Nat Rev Clin Oncol"},{"key":"3957_CR42","doi-asserted-by":"crossref","unstructured":"Casal JI, Bartolom\u00e9 RA. Beyond N-Cadherin, relevance of cadherins 5, 6 and 17 in cancer progression and Metastasis. IJMS. 2019;20(13):3373.","DOI":"10.3390\/ijms20133373"},{"issue":"1","key":"3957_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10(1):9\u201322.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3957_CR44","doi-asserted-by":"publisher","first-page":"9510","DOI":"10.1038\/s41598-025-92974-x","volume":"15","author":"XP Zhou","year":"2025","unstructured":"Zhou XP, Sun LB, Liu WH, Song XY, Gao Y, Xing JP, et al. Development and validation of predictive models for distant metastasis and prognosis of gastroenteropancreatic neuroendocrine neoplasms. Sci Rep. 2025;15(1):9510.","journal-title":"Sci Rep"},{"key":"3957_CR45","doi-asserted-by":"crossref","unstructured":"Lin PP. Aneuploid Circulating Tumor-Derived Endothelial Cell (CTEC): A Novel Versatile Player in Tumor Neovascularization and Cancer Metastasis. Cells. 2020;9(6):1539.","DOI":"10.3390\/cells9061539"},{"issue":"4","key":"3957_CR46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0360-3016(98)00323-X","volume":"42","author":"K De Jaeger","year":"1998","unstructured":"De Jaeger K, Merlo FM, Kavanagh MC, Fyles AW, Hedley D, Hill RP. Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. Int J Radiation Oncology*Biology*Physics. 1998;42(4):717\u201321.","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"issue":"7","key":"3957_CR47","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1097\/MPA.0000000000000203","volume":"43","author":"JS Estrella","year":"2014","unstructured":"Estrella JS, Ma LT, Milton DR, Yao JC, Wang H, Rashid A, et al. Expression of Estrogen-Induced genes and Estrogen receptor \u03b2 in pancreatic neuroendocrine tumors: implications for targeted therapy. Pancreas. 2014;43(7):996\u20131002.","journal-title":"Pancreas"},{"issue":"8","key":"3957_CR48","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.5858\/arpa.2013-0195-OA","volume":"138","author":"JS Estrella","year":"2014","unstructured":"Estrella JS, Broaddus RR, Mathews A, Milton DR, Yao JC, Wang H, et al. Progesterone receptor and PTEN expression predict survival in patients with Low- and Intermediate-Grade pancreatic neuroendocrine tumors. Arch Pathol Lab Med. 2014;138(8):1027\u201336.","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"3957_CR49","doi-asserted-by":"publisher","first-page":"e1969","DOI":"10.1210\/clinem\/dgac001","volume":"107","author":"A Bla\u017eevi\u0107","year":"2022","unstructured":"Bla\u017eevi\u0107 A, Iyer AM, Van Velthuysen MLF, Hofland J, Oudijk L, De Herder WW, et al. Sexual dimorphism in Small-intestinal neuroendocrine tumors: lower prevalence of mesenteric disease in premenopausal women. J Clin Endocrinol Metabolism. 2022;107(5):e1969\u201375.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"3957_CR50","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.5301\/tj.5000259","volume":"101","author":"E Biasco","year":"2015","unstructured":"Biasco E, Antonuzzo A, Galli L, Baldi GG, Derosa L, Marconcini R, et al. Small-Bowel neuroendocrine tumor and retroperitoneal fibrosis: efficacy of octreotide and Tamoxifen. Tumori. 2015;101(1):e24\u20138.","journal-title":"Tumori"},{"key":"3957_CR51","doi-asserted-by":"crossref","unstructured":"Borghesani M, Reni A, Lauricella E, Rossi A, Moscarda V, Trevisani E, et al. Efficacy and toxicity analysis of mFOLFIRINOX in High-Grade gastroenteropancreatic neuroendocrine neoplasms. J Natl Compr Canc Netw. 2024;22(5):e247005.","DOI":"10.6004\/jnccn.2024.7005"},{"key":"3957_CR52","doi-asserted-by":"crossref","unstructured":"Zhang XB, Fan YB, Jing R, Getu MA, Chen WY, Zhang W et al. Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives. Military Med Res 2024;11(1):35.","DOI":"10.1186\/s40779-024-00535-6"},{"issue":"6","key":"3957_CR53","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jso.25657","volume":"120","author":"N Manguso","year":"2019","unstructured":"Manguso N, Nissen N, Hendifar A, Harit A, Mirocha J, Friedman M, et al. Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases. J Surg Oncol. 2019;120(6):926\u201331.","journal-title":"J Surg Oncol"},{"issue":"3","key":"3957_CR54","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.18632\/oncotarget.13632","volume":"8","author":"L Wu","year":"2017","unstructured":"Wu L, Fu J, Wan L, Pan J, Lai S, Zhong J, et al. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study. Oncotarget. 2017;8(3):4935\u201347.","journal-title":"Oncotarget"},{"key":"3957_CR55","doi-asserted-by":"crossref","unstructured":"Deguelte S, Perrier M, Hammoutene C, Cadiot G, Kianmanesh R. Surgery and perioperative management in small intestinal neuroendocrine tumors. JCM. 2020;9(7):2319.","DOI":"10.3390\/jcm9072319"},{"issue":"3","key":"3957_CR56","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1245\/s10434-024-16588-9","volume":"32","author":"M Danieli","year":"2025","unstructured":"Danieli M, Fumagalli Romario U, Radice D, Pozzi S, Spada F, Funicelli L, et al. Surgical and oncologic outcomes of primary tumor resection in patients with small intestinal neuroendocrine tumors: results from a Single-Center series over a 15-Year period. Ann Surg Oncol. 2025;32(3):2141\u20139.","journal-title":"Ann Surg Oncol"},{"key":"3957_CR57","doi-asserted-by":"crossref","unstructured":"Dijke K, Kuhlmann KFD, Levy S, Tesselaar MET. Surgical management of the primary tumor in stage IV small intestinal neuroendocrine tumors: to operate or not to operate, that is the question. Curr Oncol Rep. 2023;25(6):679\u201388.","DOI":"10.1007\/s11912-023-01405-5"},{"key":"3957_CR58","doi-asserted-by":"crossref","unstructured":"Zhou Z, Wang Z, Zhang B, Wu Y, Li G, Wang Z. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT scans in the evaluation of primary tumors and lymph node metastasis in patients with rectal neuroendocrine tumors. Front Endocrinol. 2021;12:727327.","DOI":"10.3389\/fendo.2021.727327"},{"key":"3957_CR59","doi-asserted-by":"publisher","first-page":"102256","DOI":"10.1016\/j.artmed.2022.102256","volume":"125","author":"S Chi","year":"2022","unstructured":"Chi S, Tian Y, Wang F, Zhou T, Jin S, Li J. A novel lifelong machine learning-based method to eliminate calibration drift in clinical prediction models. Artif Intell Med. 2022;125:102256.","journal-title":"Artif Intell Med"},{"key":"3957_CR60","doi-asserted-by":"publisher","first-page":"104460","DOI":"10.1016\/j.critrevonc.2024.104460","volume":"203","author":"CO Hoff","year":"2024","unstructured":"Hoff CO, Manzi J, Ferreira R, Chauhan A, Housein P, Merchant N, et al. A neuroendocrine biomarker revolution from monoanalyte to multianalyte biomarkers in non-functioning gastro-entero-pancreatic neuroendocrine neoplasms. Crit Rev Oncol\/Hematol. 2024;203:104460.","journal-title":"Crit Rev Oncol\/Hematol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03957-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03957-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03957-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:14:01Z","timestamp":1763734441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03957-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3957"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03957-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required. SEER Program is a publicly available database (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2136"}}